MAURI MARIO

Role
Administrative-Technical Staff  
Office phone
Room:
  • U08, Floor: 4, Room: 4039

Publications

  • Elli, E., Mauri, M., D’Aliberti, D., Crespiatico, I., Fontana, D., Redaelli, S., et al. (2024). Idiopathic erythrocytosis: a germline disease?. CLINICAL AND EXPERIMENTAL MEDICINE, 24(1) [10.1007/s10238-023-01283-y]. Detail

  • Crespiatico, I., Zaghi, M., Mastini, C., D'Aliberti, D., Mauri, M., Mercado, C., et al. (2024). First-hit SETBP1 mutations cause a myeloproliferative disorder with bone marrow fibrosis. BLOOD [10.1182/blood.2023021349]. Detail

  • Cordani, N., Mologni, L., Piazza, R., Tettamanti, P., Cogliati, V., Mauri, M., et al. (2023). TWIST1 Upregulation Is a Potential Target for Reversing Resistance to the CDK4/6 Inhibitor in Metastatic Luminal Breast Cancer Cells. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 24(22) [10.3390/ijms242216294]. Detail

  • Difrancesco, J., Ragona, F., Murano, C., Frosio, A., Melgari, D., Binda, A., et al. (2023). A novel de novo HCN2 loss-of-function variant causing developmental and epileptic encephalopathy treated with a ketogenic diet. EPILEPSIA, 34(12 (December 2023)), 222-228 [10.1111/epi.17777]. Detail

  • Cordani, N., Lisini, D., Coccè, V., Paglia, G., Meanti, R., Cerrito, M., et al. (2023). Conditioned Medium of Mesenchymal Stromal Cells Loaded with Paclitaxel Is Effective in Preclinical Models of Triple-Negative Breast Cancer (TNBC). INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 24(6), 1-16 [10.3390/ijms24065864]. Detail